Scrip M&A Podcast: Is Biopharma M&A In A Holding Pattern Or A ‘New Normal’

Citeline Podcasts
21/07/2025 33 min
Scrip M&A Podcast: Is Biopharma M&A In A Holding Pattern Or A ‘New Normal’

Listen "Scrip M&A Podcast: Is Biopharma M&A In A Holding Pattern Or A ‘New Normal’"

Descargar episodio Ver en sitio original

Episode Synopsis

Scrip discusses the latest M&A activity and trends with CEO Shawn Titcomb of Allele Capital and Cheryl Reicin, a partner focused on international life sciences activity at Mintz.

More episodes of the podcast Citeline Podcasts

Datamonitor Healthcare Podcast: ESMO 2025 12/11/2025
Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast) 10/11/2025
Scrip's Five Must-Know Things - Nov. 10, 2025 10/11/2025
Drug Fix: Examining George Tidmarsh’s Departure As Head Of US FDA’s Drug Center 07/11/2025
Podcast: Beyond The Checkpoint — Next-Gen Strategies In Immuno-Oncology 06/11/2025
Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast) 04/11/2025
Scrip's Five Must-Know Things - Nov. 4, 2025 04/11/2025
Drug Fix: US FDA Streamlines Biosimilar Development Requirements, Clarifies Inspection Reform 31/10/2025
Decoding Cell Differentiation: How AI Foundation Models Are Reshaping Regenerative Medicine 31/10/2025
Scrip M&A Podcast: What's Next For Dealmaking In The Obesity Space? 31/10/2025
© 2003-2025 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA